Document is current
Any future updates will be listed below
-
Authors
Dyrbekk, Anne Pernille Harlem https://orcid.org/0009-0008-7930-9153
Warsame, Abdirashid Ali
Suhrke, Pål https://orcid.org/0000-0002-3133-5503
Ludahl, Marianne Odnakk
Zecic, Nermin https://orcid.org/0009-0008-0687-424X
Moe, Joakim Oliu https://orcid.org/0009-0001-9680-6329
Lund-Iversen, Marius https://orcid.org/0000-0002-2025-4062
Brustugun, Odd Terje https://orcid.org/0000-0002-5153-8391
-
Funding
Funding for this research was provided by:
The South-Eastern Norway Regional Health Authority (2022020)
The Research fund Vestfold Hospital Trust (198223)
Research fund, Department of Pathology, Vestfold Hospital Trust
South-Eastern Norway Regional Health Authority (2018049)
Vestfold Hospital Trust
- License Information
-
More Information
Article History
Received: 26 October 2023
Accepted: 29 November 2023
First Online: 19 January 2024
Declarations
:
: Odd Terje Brustugun and Anne Pernille Harlem Dyrbekk: Roche Norway has sponsored expenses for immunohistochemical reagents.
: This study was performed in line with the principles of the Declaration of Helsinki. The Regional Ethics Committee of South-Eastern Norway (REK) approved the study, number 2009/1904, S-06402b.
: Study participants submitted informed consent, and data were anonymized for the analyses.
: The patients were informed about future publications in the informed consent, and that the data/results would be anonymized. The only images included in this publication are histopathological microscopic images.
